BiopharmaTrend.com

Virvio

Virvio

Private company
VIRVIO

Virvio is a pre-clinical biotherapeutic discovery company and world leader in computationally designed protein scaffolds called "mini-binders"‚Äč. Our platform generates mini-binder leads having antibody-like affinity and specificity yet also possessing the hyper-stability and manufacturability of small-molecule drugs. Mini-binders are small structured proteins designed completely de novo to meet the requirements of the molecular target and indication.


Founded
2015
Status
Private company
Geography
United States of America based
Funding
$0.209 M
Research papers
1

Products

No products posted yet

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page